IL151033A0 - Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use - Google Patents
Purified hepatitis c virus envelope proteins for diagnostic and therapeutic useInfo
- Publication number
- IL151033A0 IL151033A0 IL15103302A IL15103302A IL151033A0 IL 151033 A0 IL151033 A0 IL 151033A0 IL 15103302 A IL15103302 A IL 15103302A IL 15103302 A IL15103302 A IL 15103302A IL 151033 A0 IL151033 A0 IL 151033A0
- Authority
- IL
- Israel
- Prior art keywords
- diagnostic
- therapeutic use
- envelope proteins
- virus envelope
- purified hepatitis
- Prior art date
Links
- 241000711549 Hepacivirus C Species 0.000 title 1
- 108010003533 Viral Envelope Proteins Proteins 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26066901P | 2001-01-11 | 2001-01-11 | |
| US31576801P | 2001-08-30 | 2001-08-30 | |
| PCT/EP2002/000219 WO2002055548A2 (en) | 2001-01-11 | 2002-01-11 | Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL151033A0 true IL151033A0 (en) | 2003-04-10 |
Family
ID=26948130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15103302A IL151033A0 (en) | 2001-01-11 | 2002-01-11 | Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1463753A2 (en) |
| KR (1) | KR20020089371A (en) |
| CN (1) | CN1547588A (en) |
| AR (1) | AR032240A1 (en) |
| AU (1) | AU2002238502B2 (en) |
| BR (1) | BR0203518A (en) |
| CA (1) | CA2400643A1 (en) |
| CZ (1) | CZ20032164A3 (en) |
| HU (1) | HUP0302416A2 (en) |
| IL (1) | IL151033A0 (en) |
| MX (1) | MXPA02008886A (en) |
| NO (1) | NO20024325L (en) |
| PL (1) | PL363175A1 (en) |
| RU (1) | RU2313363C2 (en) |
| TR (1) | TR200202169T1 (en) |
| WO (1) | WO2002055548A2 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002257392B2 (en) | 2001-04-24 | 2007-05-10 | Innogenetics N.V. | Core-glycosylated hcv envelope proteins |
| CA2504711A1 (en) * | 2002-11-08 | 2004-05-21 | Innogenetics N.V. | Hcv vaccine compositions comprising e1 and ns3 peptides |
| EP1561470A1 (en) * | 2003-06-20 | 2005-08-10 | Innogenetics N.V. | HCV vaccines comprising the envelope-1 (E1) protein or the corresponding DNA and at least one antiviral agent |
| JP4342519B2 (en) * | 2003-09-22 | 2009-10-14 | 株式会社グリーンペプタイド | Hepatitis C virus-derived peptide |
| CN100365124C (en) * | 2005-10-27 | 2008-01-30 | 云南大学 | Determination and application of hepatitis C virus specific cDNA sequence |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69526636D1 (en) * | 1994-07-29 | 2002-06-13 | Innogenetics Nv | CLEANED HEPATITIS-C-VIRUS ENVELOPE PROTEINS FOR DIAGNOSTIC AND THERAPEUTIC USE |
-
2002
- 2002-01-11 EP EP02704649A patent/EP1463753A2/en not_active Withdrawn
- 2002-01-11 CA CA002400643A patent/CA2400643A1/en not_active Abandoned
- 2002-01-11 IL IL15103302A patent/IL151033A0/en unknown
- 2002-01-11 BR BR0203518-9A patent/BR0203518A/en not_active Withdrawn
- 2002-01-11 PL PL02363175A patent/PL363175A1/en unknown
- 2002-01-11 RU RU2002121632/15A patent/RU2313363C2/en not_active IP Right Cessation
- 2002-01-11 CZ CZ20032164A patent/CZ20032164A3/en unknown
- 2002-01-11 AU AU2002238502A patent/AU2002238502B2/en not_active Ceased
- 2002-01-11 WO PCT/EP2002/000219 patent/WO2002055548A2/en active IP Right Grant
- 2002-01-11 CN CNA028006097A patent/CN1547588A/en active Pending
- 2002-01-11 HU HU0302416A patent/HUP0302416A2/en unknown
- 2002-01-11 KR KR1020027011431A patent/KR20020089371A/en active IP Right Grant
- 2002-01-11 TR TR2002/02169T patent/TR200202169T1/en unknown
- 2002-01-11 MX MXPA02008886A patent/MXPA02008886A/en active IP Right Grant
- 2002-01-14 AR ARP020100104A patent/AR032240A1/en unknown
- 2002-09-10 NO NO20024325A patent/NO20024325L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002055548A3 (en) | 2004-08-05 |
| AU2002238502A1 (en) | 2002-07-24 |
| CZ20032164A3 (en) | 2003-10-15 |
| HUP0302416A2 (en) | 2003-10-28 |
| WO2002055548A8 (en) | 2002-10-31 |
| NO20024325D0 (en) | 2002-09-10 |
| KR20020089371A (en) | 2002-11-29 |
| RU2313363C2 (en) | 2007-12-27 |
| EP1463753A2 (en) | 2004-10-06 |
| MXPA02008886A (en) | 2003-04-25 |
| NO20024325L (en) | 2002-11-11 |
| PL363175A1 (en) | 2004-11-15 |
| CN1547588A (en) | 2004-11-17 |
| WO2002055548A2 (en) | 2002-07-18 |
| AR032240A1 (en) | 2003-10-29 |
| BR0203518A (en) | 2002-12-17 |
| AU2002238502B2 (en) | 2007-09-06 |
| AU2002238502B9 (en) | 2002-07-24 |
| TR200202169T1 (en) | 2004-06-21 |
| RU2002121632A (en) | 2004-03-20 |
| CA2400643A1 (en) | 2002-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU91326I2 (en) | Human papillomavirus vaccine Ä6,11,16,18Ü (recombinant, adsorbed) | |
| HUP0400882A3 (en) | Oncolytic virus therapy | |
| EP1391212A4 (en) | Oral preparations and supports for oral preparations | |
| SI1404347T1 (en) | 4'-substituded nucleosides for the treatment of diseases mediated by the hepatitis c virus | |
| AP2001002301A0 (en) | Inhibition of viral infection using monovalentantigen-binding proteins | |
| PL366621A1 (en) | Core-glycosylated hcv envelope proteins | |
| IL162236A0 (en) | Purified hepatitis c virus envelopeproteins for dagnostic and therapeutic use | |
| IL147969A0 (en) | Peptides that block viral infectivity and methods of use thereof | |
| AU2002220460A1 (en) | The polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits | |
| AU2158000A (en) | Treatment of hepatitis c virus infections with interleukin-10 | |
| HK1062579A1 (en) | A fusion protein for treatment of hepatitis b virus and its use thereof | |
| AU2002346530A1 (en) | Breathable blood and viral barrier fabric | |
| AU2001246331A1 (en) | Hepatitis b virus (hbv) antigenic polypeptide-heat shock protein complex and use thereof | |
| AU2002219881A1 (en) | Methods and compositions for the treatment of human immunodeficiency virus infection | |
| EP1141255A4 (en) | Modified forms of hepatitis c virus ns3 protease | |
| EP1389043A4 (en) | Foot and mouth disease virus vaccine | |
| AU2002322082A1 (en) | Pharmaceutical composition for the treatment of viral infection | |
| IL151033A0 (en) | Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use | |
| IL161138A0 (en) | Treatment of hepatitis b virus infection with human monoclonal antibodies | |
| HK1046911A1 (en) | Stabilized viral envelope proteins and uses thereof | |
| EP1113777A4 (en) | Novel hepatitis c virus peptides and uses thereof | |
| AU2002332613A1 (en) | Compositions and therapeutic methods for viral infection | |
| AU2002308593A1 (en) | Recombinant orf2 proteins of the swine hepatitis e virus and their use as a vaccine and as a diagnostic reagent for medical and veterinary applications | |
| IL151188A0 (en) | Medicament for viral diseases | |
| AU2002327531A1 (en) | Therapeutic compositions and methods for treating viral infection |